Brazil Plays Key Role In Improving Access To Medicines For All

The Role Brazil has played in changing global AIDS policy and promoting widespread access to AIDS treatment is explored in a new paper by academics from Scotland and the United States.

Brazil’s large-scale, successful HIV/AIDS treatment program is considered a model for other developing countries aiming to improve access to AIDS treatment.

But far less is known about the country’s important role in changing global norms related to international pharmaceutical policy, particularly international human rights, health and trade policies governing access to essential medicines.

Prompted by Brazil’s interest in preserving its national AIDS treatment policies during World Trade Organisation (WTO) trade disputes with the US, these efforts to change global essential medicines norms have had important implications for other countries, particularly those aiming to increase the AIDS treatment they provide.

The paper, by Elize Massard da Fonseca of the University of Edinburgh and Brazil’s Oswaldo Cruz Foundation, Amy Nunn of Brown University and Sofia Gruskin of the Harvard School of Public Health, was published online on 30 March in the journal Global Public Health.

[Elize Massard da Fonseca @ University of Edinburgh]

• Window of Hope
• AIDS in Africa
• No Second Chance (Public School Version)
• The Little Red Wagon - An Innovative Approach to HIV Education (3rd Grade Level)
• Rocksluts: The CD - a Benefit for HIV Prevention
• Basic Infection Control for Healthcare Providers
• Built To Survive: HIV Wellness Guide Fourth Edition
• The Wisdom of Whores: Bureaucrats, Brothels, and the Business of AIDS